contractpharmaMarch 02, 2021
Tag: Cryoport , ESG , supply chain
Cryoport, Inc., a provider of temperature-controlled supply chain solutions for the life sciences industry, has launched its Environmental, Social & Governance (ESG) initiative.
Jerrell Shelton, CEO of Cryoport, said, “We have always been a ‘green company’, but as we entered 2021, we were aware of the expectations that our stakeholders have of us as a global company of significant size to disclose more about the work we do in the framework of a more formal ESG program and to expand our initiatives. It is our responsibility to adapt and adjust to these requirements accordingly as interest on the part of investors, and our other stakeholders, in ESG matters has surged recently, and the current economic, public health and social justice crises have only intensified this movement. Our ESG initiative, at its core, is a means by which we can drive change and be evaluated by our stakeholders with respect to our contributions to a broad range of socially desirable goals.
“The launch of our ESG program marks our first disclosure of ESG information based on the Sustainability Accounting Standards Board (SASB) and the Taskforce on Climate-related Financial Disclosures (TCFD), which are leading global sustainability frameworks. As a company focused on delivering lifesaving therapies by providing reliable and comprehensive temperature-controlled supply chain solutions for the life sciences industry, sustainability has always been integral to our work; however, this year we began a formalized evaluation of our company’s ESG initiatives and we have elevated sustainability to be one of our key priorities for guiding our operating philosophy and corporate governance as we move forward.”
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: